ORGANIZATION OF PREVENTIVE MEASURES FOR INFECTIVE ENDOCARDITIS IN KAZAKHSTAN: A CROSS-SECTIONAL STUDY AMONG CARDIOLOGISTS
Introduction. The prevention of infective endocarditis (IE) is a crucial aspect of reducing the morbidity and mortality associated with this condition. Recent research on the global burden of disease (GBD) has documented a significant rise in the incidence of IE over the past 30 years. However, certain countries have managed to achieve a reduction in IE rates, prompting inquiries into the efficacy of cardiology services in preventing IE and adherence to established guidelines across various nations. The objective of this study is to identify the necessary initiatives to optimize the functioning of cardiology services for the prevention of IE.
Materials and methods. A cross-sectional study was conducted involving cardiology physicians. The questionnaire was structured using a Likert scale. Statistical analysis was performed using ANOVA and Fisher's methods, and data were analyzed with SPSS software (version 26.0).
Results. A total of 60 cardiology physicians participated in the survey. According to the data, more than half of the participants (85%) indicated the absence of an "Endocarditis Team" within their institutions. A significant majority of respondents (96.7%) emphasized the need to establish an interdisciplinary council. Additionally, 98.3% of the participants acknowledged the importance of creating national guidelines for the prevention of IE.
Conclusions. The results of this study indicate a significant need to optimize the functioning of cardiovascular services with a specific focus on the prevention of IE.
Zhumakyz Kussainova1, https://orcide.org/0000-0002-5356-0461
Tolkyn Bulegenov1, https://orcide.org/0000-0001-6145-9649
Zhazira Zhapar2, https://orcide.org/0000-0001-6672-1116
Sholpan Abralina1, https://orcide.org/0009-0005-1555-1993
Askar Abiltayev3, https://orcide.org/000-0003-4127-2347
Olga Tashtemirova3, https://orcide.org/000-0002-7537-2808
Guzyal Abilmazhinova3, https://orcide.org/0000-0003-0007-9890
1. Albano D., Dondi F., Gazzilli M., Giubbini R., Bertagna F. Meta-analysis of the diagnostic performance of 18F-FDG-PET/CT imaging in native valve endocarditis. JACC Cardiovasc Imaging. 2021 May. 14(5):1063–5.
2. Alkhouli M., Alqahtani F., Alhajji M., Berzingi C.O., Sohail M.R. Clinical and economic burden of hospitalizations for infective endocarditis in the United States. Mayo Clin Proc. 2020 May. 95(5):858–66.
3. Clinical protocols of the Ministry of Health of the Republic of Kazakhstan – 2019. https://diseases.medelement.com/disease/ostryi-i-podostryi-endokardit-infektsionnyi-endokardit-2019/16483 (Accessed: 27.07.2024)
4. Delgado V., Ajmone Marsan N., De Waha S., Bonaros N., Brida M., Burri H., et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023 Oct 14. 44(39):3948–4042.
5. El-Dalati S., Cronin D., Riddell J., Shea M., Weinberg R.L., Washer L. et al. The clinical impact of implementation of a multidisciplinary endocarditis team. Ann Thorac Surg. 2022 Jan. 113(1):118–24.
6. Elad B., Perl L., Hamdan A., Yahav D., Atamna A., Shaked H. et al. The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy. Infection. 2022 Feb. 50(1):57–64.
7. Freitas-Ferraz A.B., Tirado-Conte G., Vilacosta I., Olmos C., Saez C., Lopez J. et al. Contemporary epidemiology and outcomes in recurrent infective endocarditis. Heart. 2020. 106:596–602.
8. Geirsson A., Schranz A., Jawitz O., Mori M., Feng L., Zwischenberger B.A. et al. The evolving burden of drug use associated infective endocarditis in the United States. Ann Thorac Surg. 2020. 110:1185–92.
9. Giannitsioti E., Pefanis A., Gogos C., Lekkou A., Dalekos G.N., Gatselis N. et al. Evolution of epidemiological characteristics of infective endocarditis in Greece. Int J Infect Dis. 2021 May. 106:213–20.
10. Gibbons E.F., Huang G., Aldea G., Koomalsingh K., Klein J.W., Dhanireddy S. et al. A multidisciplinary pathway for the diagnosis and treatment of infectious endocarditis. Crit Pathways Cardiol. 2020 Dec. 19(4):187–94.
11. Havers-Borgersen E., Butt J.H., Ostergaard L., Bundgaard H., Smerup M., Bruun N.E. et al. Recurrent infective endocarditis versus first-time infective endocarditis after heart valve surgery. Clin Res Cardiol. 2020.109:1342–51.
12. Korean Society of Infectious Diseases, Korean Society for Chemotherapy, Korean Society of Clinical Microbiology, Korean Society of Cardiology, Korean Society of Thoracic and Cardiovascular Surgery. Clinical guideline for the diagnosis and treatment of cardiovascular infections. Infect Chemother. 2011. 43:129.
13. Lean S.S.H., Jou E., Ho J.S.Y., Jou E.G.L. Prophylactic antibiotic use for infective endocarditis: a systematic review and meta-analysis. BMJ Open. 2023 Aug 22. 13(8):e077026.
14. Li H.L., Tromp J., Teramoto K., Tse Y.K., Yu S.Y., Lam L.Y., et al. Temporal trends and patterns of infective endocarditis in a Chinese population: a territory-wide study in Hong Kong (2002-2019). Lancet Reg Health West Pac. 2022 Mar 4. 22:100417.
15. Maharaj B., Vayej A.C. Awareness and knowledge of prophylaxis for infective endocarditis in patients with severe rheumatic heart disease. SADJ. 2013 Mar. 68(2):68, 70–1.
16. Nakatani S., Ohara T., Ashihara K., et al. JCS 2017 guideline on prevention and treatment of infective endocarditis. Circ J. 2019. 83:1767–809.
17. Nappi F., Martuscelli G., Bellomo F., Avtaar Singh S.S., Moon M.R. Infective endocarditis in high-income countries. Metabolites. 2022 Jul 25. 12(8):682.
18. Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P., Gentile F. et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb.143(5).
19. Pizzi M.N., Fernández-Hidalgo N. Optimizing the diagnostic workup of infective endocarditis: an urgent need for studies focused on defining the decision-making process. J Nucl Cardiol. 2020 Apr. 27(2):609–11.
20. Quan T.P., Muller-Pebody B., Fawcett N., Young B.C., Minaji M., Sandoe J. et al. Investigation of the impact of the NICE guidelines regarding antibiotic prophylaxis during invasive dental procedures on the incidence of infective endocarditis in England: an electronic health records study. BMC Med. 2020. 18:84.
21. Sengupta S., Prendergast B., Furnaz S., Ronderos R., Almaghraby A., Asch F.M. et al. Socio-economic variations in the clinical presentation, etiology and outcome of infective endocarditis in the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry: a prospective cohort study. Eur Heart J. 2021 Oct. 12:42.
22. Sun J., Qiao Y., Zhao M., Magnussen C.G., Xi B. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of Global Burden of Disease Study 2019. BMC Med. 2023 Jun 26. 21(1):222.
23. Williams M.L., Doyle M.P., McNamara N., Tardo D., Mathew M., Robinson B. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Ther Adv Cardiovasc Dis. 2021 Jan. 15:175394472110026.
24. Wilson W.R., Gewitz M., Lockhart P.B., Bolger A.F., DeSimone D.C., Kazi D.S. et al. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021 May 18. 143(20):e963–78.
25. Yang X., Chen H., Zhang D., Shen L., An G., Zhao S. Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study. Eur J Prev Cardiol. 2022 May 27. 29(8):1277–86.
Количество просмотров: 121
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Kussainova Zh., Bulegenov T., Zhapar Zh., Abralina Sh., Abiltayev A., Tashtemirova O., Abilmazhinova G. Organization of preventive measures for infective endocarditis in Kazakhstan: a cross-sectional study among cardiologists // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (5), pp. 72-78. doi 10.34689/SH.2024.26.5.009Похожие публикации:
USING THE ROBSON CLASSIFICATION TO ESTIMATE THE CAESAREAN SECTION RATE AND LOOK FOR WAYS TO REDUCE IT
CURRENT PRACTICE IN CARING FOR PEOPLE WITH DEMENTIA
АНAЛИЗ РЕЗУЛЬТАТОВ YЛЬТРAЗВYКOВOЙ ДИAГНOCТИКИ C ДOППЛEРOГРAФИEЙ ПРИ ДOБРOКAЧECТВEННЫX И ЗЛOКAЧECТВEННЫX OПYXOЛЯX ЩИТOВИДНOЙ ЖЕЛEЗЫ
EFFECT OF SEASONAL CHANGES ON SCORPION POISON
THERAPEUTIC EFFECTS OF MELATONIN IN AN ETHANOL-INDUCED GASTRIC ULCER MODEL